Ignite Creation Date:
2024-05-06 @ 7:18 PM
Last Modification Date:
2024-10-26 @ 3:04 PM
Study NCT ID:
NCT05965141
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-07-28
First Post:
2023-04-23
Brief Title:
Aribulin Combined With Carboplatin and Bevacizumab in the Treatment of Ovarian Cancer
Sponsor:
Second Affiliated Hospital of Guangzhou Medical University
Organization:
Second Affiliated Hospital of Guangzhou Medical University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-04-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-04-23
First Submit QC Date:
July 20 2023
Study First Post Date:
2023-07-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-20
Last Update Post Date:
2023-07-28
Last Update Post Date Type:
ACTUAL